Arcadia Biosciences (RKDA) Prices 8.2M Common IPO at $8/Share

Arcadia Biosciences (Nasdaq: RKDA) announced the pricing of its initial public offering of 8,200,000 shares of its common stock at a public offering price of $8.00 per share. The shares are expected to begin trading on The NASDAQ Global Market on May 15, 2015 under the symbol “RKDA.” The offering is expected to close on May 20, 2015, subject to customary closing conditions. In addition, Arcadia Biosciences has granted the underwriters a 30-day option to purchase up to an additional 1,230,000 shares of common stock.

Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC are acting as joint lead book-running managers, and Piper Jaffray & Co. is acting as an additional book-running manager, for the offering.

You May Also Be Interested In

• SpaceX retail investors turn sellers for first time since IPO
• Lyntris launches IPO at $19-$22 per share on NYSE
• Proficient Auto Logistics to acquire Hansen & Adkins for $130M